Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Potze, Wilma ^a   Arshad, Freeha ^a   Adelmeijer, Jelle ^a   Blokzijl, Hans ^a   Van Den Berg, Arie P ^a   Meijers, Joost C M ^b   Porte, Robert J ^c   Lisman, Ton ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; RIVAROXABAN; THROMBIN;

ADULT; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; IN VITRO STUDY; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; BLOOD COAGULATION TESTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORPHOLINES; POLYSACCHARIDES; THIOPHENES; THROMBIN;

EID: 84894616687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088390     Document Type: Article

References (24)

1. Lisman T, Leebeek FW, de Groot PG. (2002) Haemostatic abnormalities in patients with liver disease. J Hepatol 37: 280-287. (Pubitemid 34833094)
2. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, et al. (2010) Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 52: 355-361.
3. Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, et al. (2010) Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 8: 1994-2000.
4. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, et al. (2005) Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41: 553-558. (Pubitemid 40289502)
5. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, et al. (2010) Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology 52: 249-255.
6. Delahousse B, Labat-Debelleix V, Decalonne L, d'Alteroche L, Perarnau JM, et al. (2010) Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis. Thromb Haemost 104: 741-749.
7. Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, et al. (2009) An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137: 2105-2111.
8. Lisman T, Porte RJ. (2010) Rebalanced hemostasis in patients with liver disease: Evidence and clinical consequences. Blood 116: 878-885.
9. Tripodi A, Mannucci PM. (2011) The coagulopathy of chronic liver disease. N Engl J Med 365: 147-156.
10. Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, et al. (2010) Hemostasis and thrombosis in patients with liver disease: The ups and downs. J Hepatol 53: 362-371.
11. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. (2011) Hypercoagulability in cirrhosis: Causes and consequences. J Thromb Haemost 9: 1713-1723.
12. Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, et al. (2008) Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 6: 2-9.
13. Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, et al. (2010) Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 44: 448-451.
14. Villa E, Camma C, Marietta M, Luongo M, Critelli R, et al. (2012) Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 143: 1253-60.
15. Intagliata N, Henry Z, Shah N, Lisman T, Caldwell S, et al. (2014) Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver International 34:26-32.
16. Lisman T, Porte RJ. (2011) Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int. 31:1063.
17. Senzolo M, Rodriguez-Castro KI, Rossetto V, Radu C, Gavasso S, et al. (2012) Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis. J Thromb Haemost 10: 1823-1829.
18. Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, et al. (2013) Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis. British Journal of Haematology;163:666-673.
19. Lisman T, Kamphuisen PW, Northup PG, Porte RJ. (2013) Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol 59: 358-366.
20. Durand F, Valla D. (2008) Assessment of prognosis of cirrhosis. Semin Liver Dis 28: 110-122. (Pubitemid 351326537)
21. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, et al. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33: 4-15. (Pubitemid 37449290)
22. Bechmann LP, Sichau M, Wichert M, Gerken G, Kroger K, et al. (2011) Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int 31: 75-82.
23. Loeffen R, Kleinegris MC, Loubele ST, Pluijmen PH, Fens D, et al. (2012) Preanalytic variables of thrombin generation: Towards a standard procedure and validation of the method. J Thromb Haemost 10: 2544-2554.
24. Bloemen S, Hemker HC, Al Dieri R. (2012) Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation. Haematologica 98:549-54.